A

Actinium Pharmaceuticals Inc
F:7AY1

Watchlist Manager
Actinium Pharmaceuticals Inc
F:7AY1
Watchlist
Price: 1.364 EUR -4.35% Market Closed
Market Cap: 40.6m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of 7AY1.

The Intrinsic Value is calculated as the average of DCF and Relative values:

7AY1 Intrinsic Value
Not Available
Base Case Scenario
Compare 7AY1 to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ATNM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Actinium Pharmaceuticals Inc

Current Assets 61m
Cash & Short-Term Investments 59.9m
Other Current Assets 1.1m
Non-Current Assets 2m
PP&E 1.7m
Other Non-Current Assets 329k
Current Liabilities 8.3m
Accounts Payable 7.7m
Accrued Liabilities 589k
Other Current Liabilities 11k
Non-Current Liabilities 35.7m
Long-Term Debt 5k
Other Non-Current Liabilities 35.7m
Efficiency

Free Cash Flow Analysis
Actinium Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Actinium Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-44.2m USD
Operating Income
-44.2m USD
Other Expenses
3.2m USD
Net Income
-41m USD
Fundamental Scores

7AY1 Profitability Score
Profitability Due Diligence

Actinium Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
hidden
Profitability
Score

Actinium Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

7AY1 Solvency Score
Solvency Due Diligence

Actinium Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
hidden
Solvency
Score

Actinium Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

7AY1 Price Targets Summary
Actinium Pharmaceuticals Inc

Wall Street analysts forecast 7AY1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 7AY1 is 4.397 EUR with a low forecast of 1.741 EUR and a high forecast of 8.147 EUR.

Lowest
Price Target
1.741 EUR
28% Upside
Average
Price Target
4.397 EUR
222% Upside
Highest
Price Target
8.147 EUR
497% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Actinium Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ATNM is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ATNM Insider Trading
Buy and sell transactions by insiders